CDT Equity Inc.

CDT Equity Inc.

Biotechnology Healthcare Naples, FL, United States CDTTW (NCM)

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has CDT Equity Inc. had layoffs?
No layoff events have been recorded for CDT Equity Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CDT Equity Inc. have?
CDT Equity Inc. has approximately 6 employees.
What industry is CDT Equity Inc. in?
CDT Equity Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CDT Equity Inc. a publicly traded company?
Yes, CDT Equity Inc. is publicly traded under the ticker symbol CDTTW on the NCM.
Where is CDT Equity Inc. headquartered?
CDT Equity Inc. is headquartered in Naples, FL, United States at 4581 Tamiami Trail North, Naples, FL 34103, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.